BioInvent International AB (publ) (STO:BINV)
Sweden
· Delayed Price · Currency is SEK 32.95
+0.10 (0.30%)
May 13, 2025, 5:29 PM CET
STO:BINV Revenue
BioInvent International AB had revenue of 22.06M SEK in the quarter ending March 31, 2025, with 271.26% growth. This brings the company's revenue in the last twelve months to 60.80M, down -0.57% year-over-year. In the year 2024, BioInvent International AB had annual revenue of 44.69M, down -37.47%.
Revenue (ttm)
60.80M
Revenue Growth
-0.57%
P/S Ratio
35.66
Revenue / Employee
515.29K
Employees
114
Market Cap
2.17B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 44.69M | -26.78M | -37.47% |
| Dec 31, 2023 | 71.46M | -254.67M | -78.09% |
| Dec 31, 2022 | 326.13M | 306.74M | 1,582.45% |
| Dec 31, 2021 | 19.38M | -127.99M | -86.85% |
| Dec 31, 2020 | 147.37M | 53.63M | 57.21% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 26.24B |
| Sectra AB | 3.30B |
| Getinge AB | 35.57B |
| Camurus AB | 1.87B |
| Medicover AB | 23.56B |
| AddLife AB | 10.42B |
| Vitrolife AB | 3.61B |
| Vimian Group AB | 4.24B |
BioInvent International AB News
- 8 months ago - Transgene and BioInvent's Oncolytic Virus BT-001 Shows Promising Antitumor Activity in Ongoing Phase I/IIa Trial in Solid Tumors that Failed Previous Treatments - Benzinga